This is the list of the largest public listed companies in the Biotechnology industry from China by market capitalization with links to their reference stock.
Company Profile:
Guangzhou Boji Medical & Biotechnological Co. Ltd
Market Cap (USD):
$396.9 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Staidson
Market Cap (USD):
$380.6 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
CARsgen Therapeutics Holdings Ltd
Market Cap (USD):
$347.3 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Beijing Hotgen Biotech Co. Ltd
Market Cap (USD):
$330.9 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Guanhao Biotech Co.,Ltd.
Market Cap (USD):
$329.0 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Shandong Sito Bio-technology Co. Ltd
Market Cap (USD):
$316.3 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Xiangxue Pharmaceutical Co.,Ltd.
Market Cap (USD):
$300.2 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Alphamab Oncology
Market Cap (USD):
$290.4 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Shenzhen Bioeasy Biotechnology Co. Ltd
Market Cap (USD):
$280.7 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Chempartner Pharmatech Co. Ltd
Market Cap (USD):
$279.2 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Zhejiang Wecome Pharmaceutical Company Ltd
Market Cap (USD):
$276.4 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Shanghai Shen Lian Biomedical Corp
Market Cap (USD):
$238.0 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Immunotech Biopharm Ltd
Market Cap (USD):
$237.6 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Mabpharm Ltd
Market Cap (USD):
$235.3 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Hvsen Biotechnology Co. Ltd
Market Cap (USD):
$218.2 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
TOT BIOPHARM International Company Ltd
Market Cap (USD):
$197.7 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
CStone Pharmaceuticals
Market Cap (USD):
$190.9 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Viva Biotech Holdings
Market Cap (USD):
$163.5 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Jacobio Pharmaceuticals Group Co. Ltd
Market Cap (USD):
$149.5 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
I-Mab
Market Cap (USD):
$129.4 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Adagene, Inc.
Market Cap (USD):
$125.0 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
HBM Holdings Ltd
Market Cap (USD):
$123.2 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Ascletis Pharma, Inc.
Market Cap (USD):
$114.3 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
JW
Market Cap (USD):
$100.8 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Zhaoke Ophthalmology Ltd
Market Cap (USD):
$100.0 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Connect Biopharma Holdings Ltd
Market Cap (USD):
$73.3 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Kintor Pharmaceutical Ltd
Market Cap (USD):
$59.6 M
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Universe Pharmaceuticals, Inc.
Market Cap (USD):
$6.1 M
(Jan. 1, 2024)
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
China Biologic Products Holdings, Inc.
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology
Company Profile:
Hard to Treat Diseases, Inc.
Country:
China
Sector:
Chinese Healthcare
Industry:
Chinese Biotechnology